Showing 24,961 - 24,980 results of 32,195 for search '(equalization OR visualization) (method OR methods)', query time: 0.40s Refine Results
  1. 24961
  2. 24962

    Prevention of tumors in treating fibrocystic breast diseases using <i>Vitex agnus-castus</i>-based herbal remedy by N. A. Omarbayeva, D. R. Kaidarova, D. Kh. Omarov, A. Askandirova, Kh. Keskin, A. Zh. Abdrakhmanova, S. A. Yessenkulova, T. G. Goncharova, A. K. Jakipbayeva

    Published 2025-03-01
    “…To assess the effectiveness of VAC against FBD.Materials and methods. In this study, 150 women aged 40+ with FBD were randomly assigned to the treatment group (n = 78) or the controls (n = 72). …”
    Get full text
    Article
  3. 24963

    Treatment of neovascular age-related macular degeneration: one year real-life results with intravitreal Brolucizumab by Settimio Rossi, Carlo Gesualdo, Ernesto Marano, Raffaele Perrotta, Maria Consiglia Trotta, Antonio Del Giudice, Francesca Simonelli

    Published 2025-01-01
    “…The aim of this study is to provide the real-life anatomical-functional and safety results, after 1 year of treatment experience with Brolucizumab.MethodsThis is a retrospective observational real-life study in which 44 patients (44 eyes) diagnosed with nAMD and treated with Brolucizumab were enrolled. …”
    Get full text
    Article
  4. 24964

    Feasibility of generating sagittal radiographs from coronal views using GAN-based deep learning framework in adolescent idiopathic scoliosis by Tito Bassani, Andrea Cina, Fabio Galbusera, Andrea Cazzato, Maria Elena Pellegrino, Domenico Albano, Luca Maria Sconfienza

    Published 2025-01-01
    “…This study explores the use of GANs to generate synthetic sagittal radiographs from coronal views in AIS patients. Methods A dataset of 3,935 AIS patients who underwent spine and pelvis radiographic examinations using the EOS system, which simultaneously acquires coronal and sagittal images, was analyzed. …”
    Get full text
    Article
  5. 24965
  6. 24966

    Corneal Tomographic Changes in Keratoconus Associated with Scleral Lens Wear: A Case-Control Analysis for 12-Month Follow-Up by Wei-Hsiang Lin, Tsung-Hsien Tsai, Ching-Hsi Hsiao, Chi-Chin Sun, Jiahn-Shing Lee, Ken-Kuo Lin

    Published 2025-04-01
    “…<i>Background and Objectives</i>: Scleral lenses are widely used for visual rehabilitation in keratoconus patients, but their long-term effects on corneal tomography remain unclear. …”
    Get full text
    Article
  7. 24967

    Myopic Correction with Iris-Fixated Phakic Intraocular Lenses: Twelve-Year Results by Iveta Nemcova, Jiri Pasta, Katerina Hladikova, Martin Komarc, Darina Pospisilova, Pavel Nemec, Jan Tesar, Vladimir Kratky, Martin Sin

    Published 2021-01-01
    “…Single-center retrospective cohort study. Methods. We describe the results of a cohort study that included 85 eyes of 46 myopic patients who underwent implantation of Verisyse myopia, Veriflex, and Verisyse myopia toric (all Abbott Medical Optics, Inc.) intraocular lenses. …”
    Get full text
    Article
  8. 24968

    Treat and Extend Regimen of Aflibercept in the Treatment of Type 1 Choroidal Neovascularization Secondary to Chronic Central Serous Chorioretinopathy: Three-year Follow-Up by Kustryn TB, Zadorozhnyy OS, Nasinnyk IO, Nevska AO, Troianovska KV, Pasyechnikova NV, Korol AR

    Published 2025-07-01
    “…The primary outcome was decimal best-corrected visual acuity (BCVA) at year 3.Results: Overall, mean decimal BCVA increased significantly from 0.44 (SD; 0.35) at baseline to 0.59 (SD; 0.31) at the final visit (p˂0.001). …”
    Get full text
    Article
  9. 24969
  10. 24970

    Manual Therapy for Cervical Radiculopathy: Effects on Neck Disability and Pain &ndash; A Systematic Review and Network Meta-Analysis by Xu X, Ling Y

    Published 2025-04-01
    “…Compared to Group C, the visual analogue scale score improved by 0.74 (95% CI: − 0.04, 1.52) in Group M and by 0.61 (95% CI: − 0.18, 1.40) in Group MT. …”
    Get full text
    Article
  11. 24971
  12. 24972

    Prognostic factors in the treatment of polypoidal choroidal vasculopathy with conbercept: a post hoc analysis of the STAR study by Tsung-I. Wang, Jinfeng Qu, Ran Tang, Xuan Shi, Xin Ying, Ye Tao, Xiaoxin Li

    Published 2025-06-01
    “…Methods In the STAR study, 249 participants were randomized to either the 3 + Q12W (3 monthly injections followed by injections every 12 weeks) or 3 + TAE (3 monthly injections followed by treat and extend regimen) group. …”
    Get full text
    Article
  13. 24973

    Clinical Outcomes of Combined Implantation of an Extended Depth of Focus IOL and a Trifocal IOL in a Korean Population by Ji Eun Song, So Young Han, Ramin Khoramnia, Tamer Tandogan, Gerd U. Auffarth, Chul Young Choi

    Published 2021-01-01
    “…Methods. This prospective study enrolled consecutive patients undergoing lens phacoemulsification of cataract and combined implantation of an EDoF IOL in the dominant eye and a trifocal IOL in the nondominant eye. …”
    Get full text
    Article
  14. 24974

    Incidence, Indications, and Outcomes of Yag Capsulotomy In Eyes Implanted with an Accommodating Intraocular Lens by Robert Edward T. Ang, MD, Angela Adelaida J. Samano, MD, Rosalie Mae M. Reyes, MD, Emerson M. Cruz, MD, Albert G. Dela Cruz, MD, Maria Luisa Patricia C. Solis, MD

    Published 2013-06-01
    “…Objectives: To report the incidence of capsular changes in Crystalens-implanted eyes and analyze the indications and outcomes of yag capsulotomy. Methods: We reviewed the records of 411 eyes of 258 patients implanted with the Crystalens IOL. …”
    Get full text
    Article
  15. 24975
  16. 24976
  17. 24977

    Effects of esketamine combined with thoracic paravertebral block on postoperative early sleep in patients undergoing thoracoscopic lobectomy by LI Wenyan, ZHANG Yong, ZHANG Chen, SHI Li

    Published 2024-12-01
    “…Objective To observe the effects of continuous intravenous infusion of esketamine combined with thoracic paravertebral nerve block (TPVB) on postoperative early sleep, analgesia, and recovery quality in patients undergoing thoracoscopic lobectomy. Methods A total of 76 patients scheduled for elective thoracoscopic lobectomy at Nanjing First Hospital from January 2023 to January 2024 were randomly divided into two groups: the control group (C group) and the esketamine group (E group), with 38 patients in each group. …”
    Get full text
    Article
  18. 24978

    Efficacy and Safety of Non-Pharmacological Therapies for Primary Dysmenorrhea: A Network Meta-Analysis by Liu J, Wang Y, Zhang J, Fan X, Chen H, Zuo G, Wang X, She Y

    Published 2025-02-01
    “…Jun Liu,1,2,&ast; Yu Wang,1,&ast; Juncha Zhang,1,2 Xisheng Fan,1,2 Hao Chen,1 Guang Zuo,1 Xuesong Wang,1 Yanfen She1,2 1College of Acupuncture-Moxibustion and Tuina, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, People’s Republic of China; 2Hebei International Joint Research Center for Dominant Diseases in Chinese Medicine and Acupuncture, Hebei University of Chinese Medicine, Shijiazhuang, Hebei, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Xuesong Wang; Yanfen She, College of Acupuncture-Moxibustion and Tuina, Hebei University of Chinese Medicine, No. 3 Xingyuan Road, Shijiazhuang, Hebei, 050200, People’s Republic of China, Email wangxuesong@hebcm.edu.cn; 875107987@qq.com; sheyanfen@163.comBackground: This network meta-analysis (NMA) aimed to explore the impact of Non-pharmacological therapies (NPT) on alleviating primary dysmenorrhea (PD) symptoms and assess the effectiveness differences among various NPT.Methods: We searched seven databases and summarized clinical trials of PD treated with NPT from inception to September 6, 2023. …”
    Get full text
    Article
  19. 24979

    Comparative Evaluation of Efficacy and Complications Between Biportal Endoscopic Lumbar Interbody Fusion and Minimally Invasive Transforaminal Lumbar Interbody Fusion for Lumbar De... by Hu Q, Xiao K, Nan JN, Jhang SW, Chen CM, Lin GX

    Published 2025-04-01
    “…Qianqin Hu,1 Keyi Xiao,2 Jin-Niang Nan,3 Shang-Wun Jhang,4 Chien-Min Chen,4– 6,&ast; Guang-Xun Lin7,&ast; 1First Department of Orthopedics, Jiangxi Province Hospital of Integrated Chinese and Western Medicine, Nanchang, Jiangxi, People’s Republic of China; 2The School of Clinical Medicine, Fujian Medical University, Fuzhou, Fujian, People’s Republic of China; 3Department of Clinical Medicine, Nanchang Medical College, Nanchang, Jiangxi, People’s Republic of China; 4Division of Neurosurgery, Department of Surgery, Changhua Christian Hospital, Changhua, Taiwan; 5Department of Leisure Industry Management, National Chin-Yi University of Technology, Taichung, Taiwan; 6Department of Biomedical Sciences National Chung Cheng University, Chiayi, Taiwan; 7Department of Orthopedics, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, People’s Republic of China&ast;These authors contributed equally to this workCorrespondence: Chien-Min Chen, Email 96015@cch.org.tw Guang-Xun Lin, Email linguangxun@hotmail.comObjective: To effectuate a comprehensive juxtaposition of the clinical implications, incidence of complications, and successful fusion rates observed in the context of biportal endoscopic lumbar interbody fusion (BE-LIF) and minimally invasive transforaminal lumbar interbody fusion (MI-TLIF).Methods: The present research initiative involved an exhaustive exploration of pertinent scholarly literature in renowned databases, which lasted until April 2023. …”
    Get full text
    Article
  20. 24980

    Investigating the Efficacy and Safety of the CyberKnife System for Treating Primary Pancreatic Cancer with Metastases to the Gastrointestinal Tract by Zhang Z, Tian B, Xu H, Huang H, Liang X, Bo C, Bian Y, Wei M, Zhao Z

    Published 2025-08-01
    “…Zunhao Zhang,1,&amp;ast; Bo Tian,1,&amp;ast; Hui Xu,1 He Huang,1 Xianwei Liang,1 Changwen Bo,1 Yunfei Bian,1 Ming Wei,2 Zhitao Zhao3 1Department of Oncology, The First Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China; 2Department of General Surgery, Hebei Key Laboratory of Colorectal Cancer Precision Diagnosis and Treatment, The First Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, People’s Republic of China; 3Intensive Care Unit, The First Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China&amp;ast;These authors contributed equally to this workCorrespondence: Ming Wei, Department of General Surgery, Hebei Key Laboratory of Colorectal Cancer Precision Diagnosis and Treatment, The First Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, People’s Republic of China, Tel +86-18633888663, Email 314926509@qq.com Zhitao Zhao, Intensive Care Unit, The First Hospital of Hebei Medical University, Shijiazhuang, People’s Republic of China, Tel +86-18032808723, Email tsld60@163.comObjective: This study aimed to investigate the effectiveness and safety of CyberKnife in the treatment of primary pancreatic cancer with metastases to the gastrointestinal tract (ie, primary pancreatic adenocarcinoma metastasizing to gastrointestinal organs).Methods: A total of 106 patients with primary pancreatic cancer and metastases to the gastrointestinal tract admitted to our hospital received CyberKnife treatment. …”
    Get full text
    Article